microRNA replacement therapy for mature B cell neoplasias

Project Information

HEAL-BY-MIRNA

Grant agreement ID: 713728

DOI 10.3030/713728

Project closed

EC signature date 25 April 2016

Start date 1 May 2016

End date 31 October 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 149 750,00

EU contribution € 149 750,00

Coordinated by

CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma

Author(s): Nahikari Bartolomé-Izquierdo, Virginia G. de Yébenes, Angel F. Álvarez-Prado, Sonia M. Mur, Juan A. Lopez del Olmo, Sergio Roa, Jesus Vazquez and Almudena R. Ramiro
Published in: Blood, 2017, Page(s) 2408-2419, ISSN 0006-4971
Publisher: American Society of Hematology

Intellectual Property Rights

Patent (4)

MIRNAs AND COMBINATIONS THEREOF FOR USE IN THE TREATMENT OF HUMAN B CELL NEOPLASIAS

Application/Publication number: European Patent 17382740
Date: 2017-12-11
Applicant(s): CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

MIRNAs AND COMBINATIONS THEREOF FOR USE IN THE TREATMENT OF HUMAN B CELL NEOPLASIAS

Application/Publication number: European Patent 17382740
Date: 2017-12-11

MiRNA compositions for the treatment of mature B-cell neoplasms

Application/Publication number: PCT EP2016/060927
Date: 2015-11-15
Applicant(s): CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

MiRNA compositions for the treatment of mature B-cell neoplasms

Application/Publication number: PCT EP2016/060927
Date: 2015-11-15